Multiple studies have observed that CXCL5 is overexpressed in non-small cell lung cancers (NSCLCs) and its expression was correlated with unfavorable prognosis in patients with NSCLC [33,86]. This evidence concerns the gene CXCL5 and non-small cell lung carcinoma.